Efficacy Study of Cognitive Intervention in Amnestic Mild Cognitive Impairment (CogMCI)
A Multicenter, Randomized Trial to Assess Efficacy of Home-based and Group Cognitive Intervention Programs in Amnestic Mild Cognitive Impairment
- There will be a significant difference in cognitive function between cognitive intervention group (group therapy) and a wait list control group.
- There will be a significant difference in cognitive function between a home-based cognitive intervention group and a wait list control group.
Tutkimuksen yleiskatsaus
Tila
Tila
Ehdot
Ehdot
Interventio / Hoito
Interventio / Hoito
Yksityiskohtainen kuvaus
Opintotyyppi
Opintotyyppi
Ilmoittautuminen (Todellinen)
Ilmoittautuminen
Vaihe
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
Ansan, Korean tasavalta
- Korea University Medical College
-
Bucheon, Korean tasavalta, 420-767
- Soonchunhyang University Hospital
-
Bucheon, Korean tasavalta
- Bucheon St. Mary's Hospital, The Catholic University of Korea
-
Busan, Korean tasavalta
- Pusan National University Hospital
-
Busan, Korean tasavalta, 602-715
- DongA University Hospital
-
Daejun, Korean tasavalta, 302-799
- Daejun Eulji University Hopistal
-
Goyang, Korean tasavalta
- NHIC Ilsan Hospital
-
Goyang, Korean tasavalta, 412-270
- MyongJi Hospital
-
Incheon, Korean tasavalta, 400-711
- Inha Univeristy Hospital
-
Jeju, Korean tasavalta
- Jeju National University Hospital
-
Pusan, Korean tasavalta
- Maryknoll Hospital
-
Seongnam, Korean tasavalta
- bobath Memorial Hospital
-
Seoul, Korean tasavalta
- Inje University Sanggye Paik Hospital
-
Seoul, Korean tasavalta, 135-710
- Sungkyunkwan University, Samsung Seoul Hospital
-
Seoul, Korean tasavalta, 431-060
- Asan Medical Center, Psychiatry
-
Seoul, Korean tasavalta
- Konkuk University Medical Cener
-
Suwon, Korean tasavalta
- Ajou University Hospital
-
Yongin, Korean tasavalta
- Hyoja Geriatric Hospital
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- 50 to 85 years of age
- memory complaint corroborated by a participant and an informant
- delayed recall score on the Seoul Verbal Learning Test (SVLT) below 1.0 standard deviations from the mean of the age and education-normative values among the Korean population
- Global CDR score is 0.5, Memory CDR score is 0.5 or 1.
- above 1.5 standard deviations from the mean of normative data of the respective age- and education-matched population on the Korean Mini-Mental State Examination
- normal functional activities
- not diagnosed with dementia
- Modified Hachinski Ischemic Score (HIS): 0-4
- brain magnetic resonance imaging or CT showing no clinical evidence of other diseases (i.e., normal pressure hydrocephalus, brain tumor, cerebrovascular disease) capable of producing cognitive impairment.
- Subjects are also required to have a reliable caregiver who meet the patient at least once a week and is sufficiently familiar with the patient to provide the investigator with accurate information.
- He/She can read and write
- written informed consent
Exclusion Criteria:
- any patient who were involved in other clinical trials or treated with experimental drug within 4 weeks
- any patients with any severe or unstable medical disease that may prevent the patient from completing all study requirements (i.e., unstable or severe asthma or cardiovascular disease, active gastric ulcer, severe hepatic or renal disease)
- any patients with clinically significant laboratory abnormalities such as an abnormal thyroid function test, abnormal low level of vitamin B12 or folate, or positive venereal disease research laboratory test
- any patients with any primary neurodegenerative disorder or psychiatric disorder other than AD (i.e., Parkinson's disease, schizophrenia, or major depressive disorder)
- any patients with any history of drug or alcohol addiction during the past 10 years
- any hearing or visual impairment that can disturb the efficient evaluation of the patient
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseiden lukumäärä
Aseet ja interventiot
Osallistujaryhmä / ArmOsallistujaryhmä / Arm |
Interventio / HoitoInterventio / Hoito |
|---|---|
|
Active Comparator: Group cognitive intervention
The cognitive training will be administered twice a week for 12 weeks, located in hospital-based outpatient memory clinics.
Each session will last approximately 90 minutes.
The cognitive training programs will be offered in group sessions consisted of 5 participants.
|
The cognitive training will be administered twice a week for 12 weeks, located in hospital-based outpatient memory clinics.
Each session will last approximately 90 minutes.
The cognitive training programs will be offered in group sessions consisted of 5 participants.
|
|
Active Comparator: Home-based cognitive intervention
The participants will do their homework for 30 minutes every business days for 12 weeks.
|
The participants will do their paper and pencil homework for 30 minutes every business days for 12 weeks.
|
|
Ei väliintuloa: Wait list Control
They will participate in cognitive intervention after ending this study.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Aikaikkuna |
|---|---|
|
Modified Alzheimer's Disease Assessment Scale-Cognitive subscale(ADAS-cog)
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
Toissijaiset tulostoimenpiteet
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Aikaikkuna |
|---|---|
|
story recall test
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Digit span forward and backward
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Word fluency test
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
color-word stroop test
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Digit symbol test
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
prospective memory test
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Mini-Mental State Examination
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
CDR-SB
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
K-AD8
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
PRMQ
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
MMQ-Strategy
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
QOL-AD
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Geriatric Depression Scale-short form
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Bayer ADL
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
CGA-NPI
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Subjective cognitive assessment
Aikaikkuna: postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
Yhteistyökumppanit ja tutkijat
Sponsori
Sponsori
Yhteistyökumppanit
Yhteistyökumppanit
Tutkijat
Tutkijat
- Päätutkija: Seong H Choi, MD, PhD, Inha University Hospital
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus
Opiskelun aloitus
Ensisijainen valmistuminen (Todellinen)
Ensisijainen valmistuminen
Opintojen valmistuminen (Todellinen)
Opintojen valmistuminen
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Arvio)
Ensimmäinen Lähetetty
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Arvio)
Viimeisin päivitys julkaistu
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
Muut tutkimustunnusnumerot
- CogMCI study
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .